Helix

The study aims to enroll 10,000 Floridians to have their exomes screened for variants indicative of familial hypercholesterolemia risk.

Patients within the project and their physicians will be able to access Genome Medical's genetic specialists to address concerns and incorporate genetic information into care.

Owlstone Medical said this week that it has initiated the Pan Cancer trial for Early Detection of Cancer in Breath, a "large-scale clinical study" that will evaluate the use of Owlstone's Breath Biopsy platform for the early detection of multiple cancer types.

The first apps will be for individuals at low risk for inherited forms of cancer and heart disease, and will require a doctor's permission.